Ari Green, MD, of the University of California, San Francisco, details the benefits of remyelination for patients with multiple sclerosis (MS), as well as the challenges faced when conducting ...
Rob Etherington drives an electric car with a personalized license plate that reads “CLENE,” as in Clene Nanomedicine, the company he leads as President and CEO: “Many people ask me, is it because ...
The therapeutic landscape for multiple sclerosis (MS) is evolving beyond modulating the peripheral immune response. New strategies are now focussed on reducing inflammation and promoting the ...
Read about the diverse array of research presented at this year's meeting, including novel technological advancements and insights into disease progression in multiple sclerosis (MS). Our top coverage ...
Two papers by UB researchers reveal important new findings as to how regeneration of myelin in multiple sclerosis fails and, potentially, more efficient ways to treat it. The findings include the ...
The loss of myelin in the cerebral cortex of multiple sclerosis (MS) patients could be recovered if oligodendrocytes, the cells that myelinate neuronal axons, work at a higher rate than they are ...
SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, today announced new preclinical data supporting the potential ...
Promotion of remyelination has opened a new therapeutic avenue, but how best to determine efficacy of remyelinating drugs remains unresolved. Although prolongation and then shortening of visual evoked ...
BUFFALO, N.Y. — Two papers by University at Buffalo researchers reveal important new findings as to how regeneration of myelin in multiple sclerosis fails and, potentially, more efficient ways to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results